An interventional study of Laparoscopic appendectomy with Hem-o-lok appendiceal stump closure in Acute Appendicitis, sponsored by Furkan Kilic. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by Furkan Kilic · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 45 studies in Appendicitis with a site in Turkey — 10 open to participants now, 12 under way, none of them phase 3. Appendicitis · Turkey.
Among the 45 studies in Appendicitis with a site in Turkey, this one has the largest enrollment of the 25 interventional ones that give a count, is one of 4 that started in 2017, is one of 23 with no phase, and was the 44th registered.
421 studies on the registry are indexed under Appendicitis; 67 are open to participants now.
Browse Appendicitis studies →10 of the 45 studies in Appendicitis with a site in Turkey are open now. Recruiting first, the newest first:
Ahmet Burak Doğan, MD · Sites in Turkey
Ages 5–17
Bursa Yuksek Ihtisas Training and Research Hospital · Sites in Turkey
Ages 18–90 · Healthy volunteers
Haydarpasa Numune Training and Research Hospital · Sites in Turkey
Ages 18–65
Ankara Etlik City Hospital · Sites in Turkey
Ages 6–18
Ahmet Burak Doğan, MD · Sites in Turkey
Ages 5–18
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 39 Appendicitis studies recruiting now, 18 (46%) set no upper age limit and 19 (49%) stop at 75 or younger; 23 take children under 18; 7 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
45 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 4 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 644 is above the median of 116 across 254 interventional studies indexed under Appendicitis.
Median enrollment 100 across the 25 interventional studies, 142 across the 20 observational. Of the 30 that completed or were terminated, 1 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 45 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Furkan Kilic as lead sponsor.
Furkan Kilic has 1 study filed under Appendicitis — fewer than ten, so there is no comparison to draw.
7 of the studies in Appendicitis with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07824908YUNUS YÜKSELEffect Of Specimen Extraction Site And Local Anesthesia On Postoperative Pain In Laparoscopic Appendectomy | 2026-12-01 |
| NCT07937514Sezgin TopuzSpecimen Integrity in Laparoscopic Appendectomy | 2027-01-01 |
| NCT07926165Haydarpasa Numune Training and Research HospitalSystemic and Tissue Inflammatory Biomarkers in Acute Appendicitis | 2027-01-12 |
| NCT07496723Sanliurfa Education and Research HospitalComparison of Diagnostic Methods in Patients Operated for Suspected Appendicitis | 2027-01-31 |
| NCT07643285Ahmet Burak Doğan, MDFeasibility and Safety of a Pediatric ERAS Protocol for Laparoscopic Appendectomy | 2027-04 |
Add all 7 to your calendar (.ics) → With an account.
Among the 45 studies in Appendicitis with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This quasi-randomized controlled trial compared the use of a single versus double Hem-o-lok polymer clip for closure of the appendiceal stump during laparoscopic appendectomy in adults with non-perforated acute appendicitis. Patients were allocated according to the parity of their hospital admission protocol number (odd: single clip; even: double clip). The primary outcome was the rate of postoperative complications within six months of surgery, graded according to the Clavien-Dindo classification.
Patients undergoing laparoscopic appendectomy for a preliminary diagnosis of acute appendicitis at a single tertiary centre between December 2017 and December 2020 were assessed. A standardised three-port technique with uniform antibiotic prophylaxis was used. Patients with perforated appendicitis, pregnancy, immunosuppression, tubo-ovarian pathology, antibiotic use outside the study protocol, or non-standard operative technique (intra-abdominal lavage, drain placement, non-Hem-o-lok stump closure, or clip number inconsistent with allocation) were excluded. Follow-up visits took place on postoperative days 7 and 30, with a telephone assessment at 6 months. Complications were defined as any deviation from the normal postoperative course within 6 months and graded with the Clavien-Dindo classification. NOTE: This study was registered retrospectively, after completion of follow-up and during peer review of the primary report; registration was not part of institutional practice for investigator-initiated surgical studies at the time the study was designed.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Appendiceal stump closed with a single Weck Hem-o-lok XL non-absorbable polymer clip (Teleflex Inc., Wayne, PA, USA). Patients with odd admission protocol numbers.
Procedure: Laparoscopic appendectomy with Hem-o-lok appendiceal stump closure
Appendiceal stump closed with two Weck Hem-o-lok XL non-absorbable polymer clips. Patients with even admission protocol numbers.
Procedure: Laparoscopic appendectomy with Hem-o-lok appendiceal stump closure
Standardised three-port laparoscopic appendectomy; stump closure with one or two Hem-o-lok XL polymer clips according to allocation; specimen extraction with an endobag; no intra-abdominal lavage, no drain.
Postoperative complications
Any deviation from the normal postoperative course, recorded regardless of its relation to the stump closure technique and graded according to the Clavien-Dindo classification.
Time frame: 6 months after surgery
Appendiceal stump leak or dehiscence
Time frame: 6 months
Hem-o-lok clip migration or erosion into the gastrointestinal tract
Time frame: 6 months
Surgical site infection
Superficial incisional, deep incisional or organ/space infection
Time frame: 6 months
Reoperation for a postoperative complication
Time frame: 6 months
Plan to share: Yes — The datasets generated and analysed during the study are available from the corresponding author on reasonable request.
Supporting information: Analytic code
Time frame: Beginning after publication of the primary results, with no end date determined.
Access criteria: Reasonable request to the corresponding author.
No publications or documents are linked to this record.
Ran from Dec 2017 to primary completion in Jun 2021, 42 months.
Of 92 non-industry interventional studies with no phase under Appendicitis, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's 42 months is above that.
Counting every sponsor, half of 94 studies reached it within 19 months; a quarter within 10 and three quarters within 37.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.